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Abstract 
In the 21st century the diagnostic needs are getting bigger and bigger. Methods that are 
established exceed in great sensitivity and efficiency, parameters that are crucial for a 
successful assay. One of the most innovative assays is the proximity ligation assay, a method 
which takes advantage of the proximity distance that two oligonucleotides can be in and upon 
ligation eventually will give a strong signal. Such method reduces background greatly while 
improves signal to noise ratios. For that reason solid phase proximity ligation assay was chosen 
to be optimized by further establishment of the microfluidic version of it. During SP- PLA, 
capture antibodies are immobilized on a solid support and the antigen binds on them making it 
possible for a PLA to take place. By the end of all reactions the signal is detected on a fluoresce 
microscope, were each product is distinguished as an individual spot. The ease and speed of 
this method implied that it could be applied into microfluidics, an application that could push 
the assay to its limits. Consequently, after optimizing the method on slides we were able to 
detect concentration of antigen as low as 1 pM. Then the optimized protocol was applied on 
microfluidic making the method much faster but not more sensitive due to restricted knowledge 
over this subject. The biggest advantage was the signal to noise ratio which was raised in very 
satisfactory levels. Further studies and experiments could make micro SP-PLA one of the most 
sensitive methods ever been made. 
Περίληψη 
Τον 21 αιώνα οι διαγνωστικές ανάγκες αυξάνονται όλο και περισσότερο. Οι τρέχοντες μέθοδοι 
υπερέχουν σε ευαισθησία και αποδοτικότητα – παράμετροι καθοριστικοί για μια επιτυχημένη 
μέθοδο. Η ανάλυση PLA στερεάς φάσης (SP-PLA) είναι μία από τις πιο καινοτόμες μεθόδους, 
η οποία εκμεταλλεύεται την κοντινή απόσταση   στην οποία μπορεί να βρεθούν δύο 
ολιγονουκλεοτίδια, τα οποία υπό μία αντίδραση σύνδεσης τελικά θα δώσουν ένα ισχυρό σήμα. 
Κατά συνέπεια, ο θόρυβος μειώνεται σημαντικά ενώ παράλληλα βελτιώνεται η σχέση θορύβου 
- σήματος. Για αυτό το λόγο η ανάλυση PLA στερεάς φάσης (SP-PLA) επιλέχθηκε για να 
βελτιστοποιηθεί με περεταίρω καθιέρωση της μικρορευστομηχανικής έκδοσής της. 
Συγκεκριμένα, κατά την SP-PLA, τα αιχμαλωτίζωντα αντισώματα ακινητοποιούνται πάνω σε 
ένα στερεό υπόστρωμα και το αντιγόνο συνδέεται σε αυτά καθιστώντας δυνατή μία μέθοδο 
PLA. Μετά το πέρας όλων των αντιδράσεων, το σήμα ανιχνεύεται μέσω ενός μικροσκοπίου 
φθορισμού,  όπου κάθε προϊόν διακρίνεται ως μία ξεχωριστή κουκίδα. Η άνεση και η ταχύτητα 
αυτής της μεθόδου συνιστούν ότι μπορεί να εφαρμοστεί σε μικρορευστομηχανική, μία 
εφαρμογή που θα μπορούσε να πιέσει τη μέθοδο στα όριά της. Στη πράξη, αφού 
βελτιστοποιήσαμε τη μέθοδο σε γυάλινα πλακίδια είχαμε τη δυνατότητα να ανιχνεύσουμε 
μέχρι και 1 pM συγκέντρωσης αντιγόνου. Έπειτα, το βελτιστοποιημένο πρωτόκολλο 
εφαρμόστηκε σε μικρορευστομηχανική καθιστώντας τη μέθοδο πιο γρήγορη, ωστόσο όχι πιο 
ευαίσθητη  λόγο περιορισμένης γνώσης επί του συγκεκριμένου θέματος. Το μεγαλύτερο 
πλεονέκτημα ήταν το γεγονός ότι η σχέση θορύβου - σήματος βελτιώθηκε σε ικανοποιητικό 
βαθμό. Περαιτέρω μελέτες και πειράματα θα μπορούσαν να κάνουν την micro SP-PLA μία 
από τις πιο ευαίσθητες μεθόδους που επινοήθηκε. 
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1 Introduction 
1.1 PLA 
The Proximity Ligation Assay (PLA) is an immunoassay where pairs of oligonucleotide- 
labeled antidodies- PLA probes- are employed to detect an antigen of interest. When two PLA 
probes bind the same antigen, the attached oligonucleotides are brought in proximity and can  
be ligated upon addition of a short complementary oligonucleotide. The ligated DNA strands 
serve as reporter molecules that can be readily detected using a variety of methods such us 
quantitative Real- Time PCR (qPCR) or Rolling Circle Amplification (RCA) [1]. 
 The technique used in this thesis is the solid phase proximity ligation assay  (SP-PLA) in 
which an antibody is immobilized on a solid support (ex. the surface of a glass slide) and acts 
as a capture reagent for the antigen [1]. Then the antigen is been added and the PLA assay is 
performed over the antibody- antigen complex (figure 1). 
 
 
Figure 1.The PLA assay. Hybridization of the primary antibody and recognition of  the antigen proceed 
at the first place. The PLA probes which are conjugated antibodies with two different oligonucleotides 
are then added  and the strands of DNA are coming in a proximity distance and with connector oligos  
it is possible for a ligation reaction to take place. For the final step, a polymerase is been used to 
amplify the circle that has been created by the ligation process creating a template of thousands of 
repetitive sequences, which are complementary with fluorescent oligos that eventually create a spot. 
The signal can be detected with a fluoresce microscope. 
 
 
1.2 Primary amines 
SP- PLA is a variation of the classical method of 
PLA, where a solid support is been used and a  
capture antibody is immobilized on it. The 
immobilization takes place by through the reaction 
of the primary amines (figure 2) on the antibody 
Figure 2. The antibody with its primary 
amines which are indicated in red boxes. 
These are the residues where the amide bond 
will be created between NHS and the antibody 
Solid support 
Signal shown as a spot under a fluoresce microscope 
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(NH2) with N-hydroxysuccinimide esters (NHS) on the solid support. NHS is commonly found 
in organic chemistry or biochemistry where it is used as an activating reagent for carboxylic 
acids. Activated acids can react with amines to form amides, a very stable bond. 
 
 
 
1.3 Solid Phase 
The solid phase of the method is a glass 
slide coated with a hydrophilic polymer 
containing N-hydroxysuccinimide (NHS) 
ester reactive groups. Planar glass slides 
constitute one of many solid supports 
used. One of the most commonly used 
support is paramagnetic microparticles 
(beads). Microparticles are commonly 
used as solid supports in immunoreactions to 
capture and separate target molecules. 
Generally, SP-PLA is very well suited for analyses of proteins 
present at low concentrations in complex biological materials such as undiluted plasma or 
serum or whole blood [2]. 
 
 
 
 
1.4 Fighting background: the golden mean 
Immunoassays in general rely heavily on the specificity of affinity reagents and detection 
strategies to report targets. This fact by itself reports that the likelihood of background creation 
can be excessively high. Background is influenced by a variety of factors: 
 Antibodies may recognize and bind to non intended proteins. 
 Antibodies may stick nonspecifically to the surface of the solid phase and generate 
signal in absence of antigen. 
 Probes may come in proximity in solution and generate signal in absence of an antigen 
A sandwich immunoassay (such as SP-PLA) which uses capture antibodies to recognize and 
bind the antigen as well as secondary detection antibodies, can improve detection limits 
especially in blood where high sensitivity is required and where background is a problem due 
to the presence of high amounts of proteins over a broad dynamic range. Minimizing 
Figures 3,4. A 
demonstration of CodeLink 
glass slides coated with 
NHS ester reactive groups 
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background then can be easier. We struggle to have zero false positive signal by altering time 
of incubations, concentration of reagents and efficient blocking methods. Nonetheless, 
background reduction usually lead to decrease of the true signal. The ‘golden’ ratio between 
signal and background should be found for any immunoassay to be efficient and extremely 
sensitive, a discovery that takes huge amounts of time and effort because of the vast number of 
combination of conditions that can be used for that purpose.  
 
1.5 Rolling Circle Amplification (RCA) 
The RCA method is the most important tool for  a succesfull PLA. It is the last step of the 
method during which Φ29 polymarase replicates a circural DNA thousands of times, creating a 
very long linear single- stranded DNA which contains many repetative sequences of the 
circural DNA. Then, using small single- standred fluorecenced complementary DNA 
oligonucleotides, it is possible to detect the whole rolling circle product (RCPs), which can be 
seen under a fluorence microscope as an individual dot.  
 
 
1.6 Φ29 DNA  polymerase: a peculiar enzyme 
  In order to perform RCA, this very special polymerase is being used. Φ29 DNA polymerase is 
an enzyme from the bacteriophage Φ29 
  Φ29 is a bacteriophage of Bacillus subtilis with a sequenced, linear, 19,285 base pair DNA 
genome [3]. Each 5' end is linked to a terminal protein, which is essential in the replication 
process. A symmetrical mode of replication has been suggested, whereby protein-primed 
initiation occurs non-simultaneously from either end of the chromosome; this involves two 
replication origins and two distinct polymerase monomers. Synthesis is continual and involves 
a strand displacement mechanism. This was demonstrated by the ability of the enzyme to 
continue to copy the singly primed circular genome of the M13 phage more than tenfold in a 
single strand (over 70kb in a single strand) [4]. In vitro experiments have shown that Φ29 
replication can proceed to completion with the sole phage protein requirements of the 
polymerase and the terminal protein. The polymerase catalyses the formation of the initiation 
complex between the terminal protein and the chromosome ends at an adenine residue. From 
here, continual synthesis can occur. 
The polymerase (figure 5), is a monomeric 
protein with two distinct functional domains. 
Site-directed mutagenesis experiments support 
the proposition that this protein displays a 
structural and functional similarity to the 
Klenow fragment of the Escherichia coli 
Polymerase I enzyme [5]. It comprises a C-
terminal polymerase domain and a spatially 
separated N-terminal domain with a 3'-5' 
Figure 5.Phi29 DNA Polymerase with Substrate 
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exonuclease activity. The isolated enzyme has no intrinsic helicase activity, but may carry out 
an equivalent function by way of its strong binding to single stranded DNA, particularly in 
preference to double stranded nucleic acid. The exonuclease activity of the enzyme is, like its 
polymerisation activity, highly processive and can degrade single stranded oligonucleotides 
without dissociation [6].  
It is being increasingly used in molecular biology for multiple displacement DNA amplification 
procedures, and has a very unique characteristic that makes it the ideal enzyme for this method:  
constant polymerization of a circular, single strand DNA into a long linear repetitive one. This 
long linear DNA is actually the amplified product that can be observed microscopically.  
 
1.7 T4 DNA ligase: a crucial enzyme for a successful PLA  
DNA ligases are divalent metal cation-dependent enzymes that utilize ATP or NAD+, 
depending on the ligase, to catalyze phosphodiester bond formation between adjacent double-
stranded polynucleotide termini possessing a 3′-hydroxyl and a 5′-phosphate [7]. A typical 
DNA ligase catalyzes the formation of the phosphodiester bond in 3 steps: during step 1, an 
adenylyl group is transferred from ATP to the lysine in the active site of the enzyme. Then, in 
step 2, the adenylylated enzyme transfers the adenylylate group to the 5’- phosphate end of 
DNA creating a media form of adenylylated DNA (AppDNA). In step 3, a nucleophilic attack 
of 3’-hydroxyl on the App group causes the formation of the phosphodiester bond and the 
release of AMP (figure 6). All steps are metal cation- dependent, by the ion Mg
+2
 [7], [8].  
 
Figure 6. The 3 steps of the reaction of formation of phosphodiester bond on DNA by  DNA ligase 
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1.8 A closer look to the method 
Everything beggins with the immobilization of the capture antibody on the glass surface. Using 
NHS esters and the NH2 groups of the antibody the following reaction takes place: 
 
NHS-Esters react with α-amine groups of the antibody to form amide bonds. A covalent amide 
bond is formed during the reaction, releasing N-hydroxysuccinimide. This bond is a covalent 
bond, so it is very unlikely that the antibody will be washed away. 
The second step of the method is the capture of the antigen by the capture antibody on the 
surface. The reaction time can be minimized inside the microfluidic channel because of the 
very small dimensions of it. The diffusion time is given by the equation: 
  
  
  
 
D is the diffusion coefficient which is 4,6.10
-7
 cm
2
/sec for an IgG antibody of 150kDa weight. 
This equation implies that the time that a capture antibody  takes to bind to an antigen is only 
2,4 sec in a distance of 15μm.  
PLA probes are then added. These probes consists of 2 antibodies, one PLUS anti-mouse IgG 
and one MINUS anti-mouse IgG. The terms PLUS and 
MINUS refer to two poluclonal antibodies spefied for a 
very spesific antigen and they cary two different strands 
of DNA (olus and minus). For the formation of the circle 
2 additional oligos are required: S3 backbone and S3 
splint. Backbone has a small part of its 3’ and 5’ ends 
complementary with the DNA on the 2 probes. Splint is 
complimentary to the  probe’s DNA but is located 
between the two ends of the backbone, as it shown in 
figure 7. These two DNA pieces have their 5’ ends 
phosphorilated for a successful ligation to be performed.  By a ligation process, the whole 
circle closes and it is ready for the amplification process through an RCA. 
  
1.9 Microfluidics: Lab on a chip 
The earliest microfluidic devices demonstrated that fluidic components could be miniaturized 
and integrated together, leading to the idea that one could fit an entire “lab on a chip”, in much 
the same way that a microelectronic circuit is an entire computer on a chip. Since then, there 
has been tremendous interest in harnessing the full potential of this approach and, 
backbone 
splint 5’ 3’ 
Ligation sites 
5’ 5’ 3’ 3’ 
Figure 7. structure of the circle 
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consequently, the development of countless microfluidic devices and fabrication methods. 
Microfluidics have many advantages, which makes them ideal for using in many applications.  
One obvious advantage is that miniaturized components and processes use smaller volumes of 
reagents, thus leading to reduced reagent consumption. This decreases costs and permits small 
quantities of precious samples to be used more effectively (ex. antibodies, probes, samples 
etc.). 
At the small scales in microfluidic devices, diffusive mixing is fast, often increasing the speed 
of reactions. Dramatic performance improvements are often seen in microfluidic assays such 
as: reduced measurement times, improved sensitivity, higher selectivity, and greater 
repeatability. 
Many microfluidic technologies permit the construction of devices containing multiple 
components with different functionalities. A single integrated chip could perform significant 
biological or chemical processing from beginning to end, for example the sampling, pre-
processing, and measurement involved in an assay. This is the kind of vision that led to the 
terms “lab-on-a-chip” and “micro total analysis system (μTAS)”.Such system offers the 
potential for high efficiency, simultaneous analysis of a large number of biologically important 
molecules in genomic, proteomic and metabolic studies [9]. Performing all fluid handling 
operations within a single chip saves time, reduces risk of sample loss or contamination, and 
can eliminate the need for expensive laboratory robots. Furthermore, operation of microfluidic 
devices can be fully automated, thus increasing throughput, improving ease of use, improving 
repeatabilty, and reducing the element of human error. 
2 Materials and methods  
 The whole experimental procedure was divided into several phases, each of which was aimed 
to optimize different experimental conditions. We started by immobilizing antibodies on plastic 
slides and continued with glass slides. In an attempt to compare the two types of solid supports. 
In addition, we investigated different blocking approaches for each type of support. The next 
phase intended to optimize probing dilutions and eventually combine everything into a single 
optimized protocol, which would be used for the last phase, which was integration to  
microfluidics.    
2.1 Immobilization protocol (Sigolis plastic slides) 
 
The antibodies were initially immobilized on a plastic slide provided by Sigolis (Uppsala, 
Sweden). The slides were coated with PhenylDextran in the following way: a drop of water 
was dropped on the surface of the slide for the hydrophobicity to be evaluated, followed by a 
wash with distilled water. The slides were then dipped into 60% and then 96% ethanol and after 
the ethanol evaporated, they were dipped into 0.1% of Dextran for 30 minutes under soft 
agitation on a Stuart® mini orbital shaker, SSM1 in room temperature. Finally, a last wash with 
distilled water took place and the hydrophobicity of the slide was evaluated again with a drop 
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of water and by comparing it with the previous result, before the coating procedure. The coated 
slides were stored at 4°C. 
Different hybridization chambers were used according to the needs of each individual 
experiment: 
 Secure seal™ hybridization chamber gasket, eight chambers, 9mm diameter, 0,8mm 
deep (Invitrogen™, Eugene, Oregon, USA) 
 Secure seal™ hybridization chamber gasket, one chamber, 22mm x 22mm, 0,8 deep 
(Invitrogen™, Eugene, Oregon, USA) 
 Secure-Seal™ Hybridization chamber gasket, one chamber, 20 mm diameter, 0.8 mm 
deep (Invitrogen™, Eugene, Oregon, USA) 
The appropriate mask was placed on the slides and then Sodium Periodate 5mM (NaIO4) was 
added until the mask was full and  incubated for 30 min in the dark. After a wash with 1x PBS 
pH=7.4 for 1- 3 mins, 50% of glycerol was added for 10min followed by another wash with 
1x PBS. Then the antibody was added. The antibody that was used, was a mouse IgG (16.6 
μM diluted in 0.1nM sodium bicarbonate, pH= 9.6). The incubation time was 2 hours at room 
temperature. After the time elapsed, the antibodies were removed from the mask. 10μL of 
cyanoborohydride (NaCNBH3) 5 M were added and the mixture was placed back in the masks 
for 30 min at room temperature. All procedures took place in a hood because of the high 
toxicity of NaCNBH3. After a wash with 1x PBS, Tris-HCl was added and the incubation was 
held for 10 min at room temperature.  
 
2.2 PLA probes and detection protocol 
All the reagents and enzymes that were used, were provided by Olink Bioscience (Uppsala, 
Sweden), as a part of Duolink In situ PLA kit. At the beginning, PLA probes that were diluted 
in 1:5 ratio were prepared in Antibody Diluent. Before addition of the PLA probes, the masks 
were washed with 1x TBS. Incubation took place in a pre- heated humidity chamber for 1 
hour at 37°C.  
The first step of the detection protocol was the ligation, in which the enzyme T4 ligase was 
used. The enzyme was added in the Olink’s Ligation stock and incubated for 30 min in a 
preheated humidity chamber at 37ºC. For the amplification step, Φ29 polymerase was used in  
olink’s amplification stock with high purity water. The incubation time was 100 min in a 
preheated humidity chamber at 37ºC. In each individual step washings were performed with 
1x PBST (1x PBS 0.1%, Tween 20%). 
At the final step, detection of the product was performed. Before the masks were removed, the 
slides were engraved with a diamond pen on the opposite surface at the places there the masks 
were, so that it would be easier to macroscopically detect the sites that the products were 
without the masks. Then the slide was dipped consecutively into 70%, 85% and 99% of 
ethanol for 2 min each, to dehydrate. The slide was let to dry and then a drop of vectashield 
mounting medium for fluorescence H-1000 (Vector Laboratories INC. CA, USA) was added 
on top of the slide. The slide was then covered with a glass cover slip (Menzel- Gläser, 24x55 
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mm) and observed in a fluorescence microscope at Cy 3.5 and magnification 20x. To count 
the rolling circle products (RCPs), Image J was used.  
 
2.3 Immobilization protocol (CodeLink™ glass slides) 
 Because of the fact that CodeLink™ Activated glass slides (SurModics INC. USA) were 
coated with NHS, the immobilization protocol needed to be adapted. The activation of 
chemical groups was not necessary anymore and the glass was hydrophilic by itself. Therefore 
there was no need of making it hydrophilic as with the hydrophlic Sigolis plastic slides.  
After the appropriate mask was applied, the antibody was added inside the chambers and 
immobilization took place at room temperature for 2 hours. In order to test which 
concentration of capture antibody (anti mouse IgG) is the most efficient, 3 different 
concentrations were prepared: 5, 50 and 500 nM. All were diluted in carbonate buffer pH=9.6.    
   
 
2.4 Blocking on Sigolis slides 
An 8- chamber mask was placed onto the sigolis plastic slide so that different blocking 
conditions could be tested. For the experiment 0.1%, 1% and 10% of BSA were used. After 
activating the Dextran on the slide as described above, the mouse IgG antibody was mixed with 
the different concentrations of BSA to a final concentration of 1nM. A layout of the experiment 
can be seen below: 
 
 
All reactions in row A contained mouse IgG, while in row B were the antigen independent 
background was tested, no antibody was added. Incubation was performed at room 
 
 
 
   
   
Antibody + 
Antibody - 
0.1
% 
1.0
% 
10
% 
0% of BSA 
2 1 3 4 
A 
B 
Figure 8.  layout of the blocking conditions in the mask 
Optimization and establishment of a micro Solid Phase Proximity Ligation Assay, G. Flamourakis 
 
14 
 
temperature for 1 hour. After a wash with 1x PBS, PLA probes and detection protocol was 
performed, as described in materials and methods. 
 
2.5 Blocking on CodeLink™ slides  
  To test blocking on Codelink slides, first the capture antibody was added. This was an anti- 
mouse IgG in concentration 2μg/μL, diluted in Carbonate Buffer pH=9.6. For the experiment, 
the antibody was diluted in carbonate buffer to 500nM (for 400μL of reaction 15,2 μL of 
antibody were diluted in 384,8μL Carbonate Buffer). Immobilization took place for 2 hours at 
room temperature. After immobilization, various blocking reagents were used, to evaluate 
which gave the best results taking into consideration true signal and noise. Blockings that used 
were: 
1. Starting Block (Thermo Scientific) 
2. Blocking buffer (Thermo Scientific) 
3. SEA block (Thermo Scientific) 
4. Super Block (Thermo Scientific) 
5. DuoLink blocking buffer (Olink) 
In all blocking solutions, 0.1% mg/ml salmon sperm DNA was added and all were incubated 
for 30 min at room temperature. After removing the blocking solutions, a wash with 1x PBS 
was performed and the mouse IgG antibody, 1nM, was inserted. Then the regular protocol of 
detection was performed.  
 
2.6 Different concentrations of antigen
1
 
The sensitivity of the method was evaluated. Different concentrations of antigen were used: 
0, 1, 10, 50 pM and the layout of the experiment is shown in figure 9:  
 
                                                             
1 Mouse IgG is referd to as antigen not to be confused with the capture antibody (anti- mouse IgG). 
 
 
 
   
   
SuperBlock 
No Blocking 
0pM 1pM 10pM 50pM  
2 1 3 4 
A 
B 
Figure 9. layout of the experiment with different concentrations of antigen 
Optimization and establishment of a micro Solid Phase Proximity Ligation Assay, G. Flamourakis 
 
15 
 
Super block was tested compared to no blocking. Column 1 served as a background test. 1μL 
of antibody was added in 1660 μL of carbonate buffer to a final concentration of 
10nMfollowed by a second dilution 1:10 dropped the concentration in 1nM. Consequently, 
this dilutant was used to make all the different concentrations, as shown on the table: 
 
Table 1 dillutants of antigen 
Concnentration (pM) Vantigen 1nM (μL) Vcarbonate (μL) Vfinal (μL) 
0 0 100 100 
1 1 999 1000 
10 1 99 100 
50 5 95 100 
 
Furthermore, the efficiency of storing the already immobilized slide in 4ºC was tested. So, 2 
slides where prepared, but slide no.1 was kept in the freezer for the whole weekend, whereas 
slide no.2 was used the same day (no storage). Slide no.1 was kept in the freezer with the mask 
on it and the capture antibodies inside the chambers. 
 
2.7 Probe titrations 
Figure 10.  layout of the probe experiment's mask 
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The efficiency of using different dilutions of the Olink’s Duolink in situ PLA probes PLUS and 
MINUS (see introduction 1.8, closer look to the method) was tested. Dilutions used were: 1:10, 
1:5 and 1:1. The layout of the mask was as it is illustrated. Furthermore, the dilutions were 
tested alongside with two Blockings that gave the best results in previous experiments so that it 
is easier to reach an optimized protocol. Again, two slides were used, the one with antigen and 
the other without.  
 
2.8 Moving into microfluidics   
Having optimized conditions for blocking, capture and detection we proceeded to perform SP- 
PLA in microfluidics. 
The following components were used, and assembled in order to run the microfluidic 
experiments 
 
 
 
 
 
 
 
 Automated compressed air slide holding device  
 
 
 
   
   
1:1 1:5 1:10   
2 1 3 4 
 
 
 
 
SuperBlock 
Blocking buffer 
1:1 
1:10 
 
No blocking 
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This device was used in order to hold together and with great pressure the slides, the PDMS 
mask where the microfluidic channels were in and the guides for the tubes. All the components 
were aligned together by the assistance of two metallic cylinder holders, which guide all the 
components through two holes on each side of the device. The slide and all the other 
components were held by an aluminum platform which was raised to the level of the plastic 
selling by a hydraulic cylinder, which moved upwards and downwards with the assistance of 
compressed air. Compressed air was provided by a Biltema compressor OL 15-6 and 0.4MPa 
of pressure was applied. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
At the design above, it is demonstrated how the layout of the device is: 
1. Plastic selling with 15 guide holes 
2. Metallic guide cylinders 
3. Silicon mask with 15 microfluidic channels 
4. Slide 
5. Aluminum holding platform 
6. Piston 
7. Hydraulic cylinder device 
8. Aluminum holdings 
 Syringe pump 
1 
2 2 
3 
4 
5 
6 
7 
8
2 
 2 
8 
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The stable flow through the channels was succeeded by the help of a programmable PHD 
2000 syringe pump (Harvard Apparatus 84, October Hill Roa, Holliston MA  01746, United 
States) and a 1mL plastic syringe (diameter 5mm). With the command ‘withdraw’ the 
syringe sucked the reagents with a tube (1/32’’) and by the command ‘diffuse’ the liquid 
was lead into the channels.  
 
 Standard uProcess™ Kit 
This kit was provided by Labsmith (LabSmith, Inc. | 6111 Southfront Road, Suite E | 
Livermore, CA 94551) and it is a breadboard on which the whole microfluidic circuit could 
be applied. It was modified to be able to test 4 different channels simultaneously. The kit 
contained 2 reservoirs, 2 pumps with two 80μL syringes, two automated valves and some 
adaptors to connect it to the pc.  
 
All fittings of the kit were for 360μm tubings. The microfluidic circuit was:    
 
  
 
 
 
 
 
1. 80μL syringe  
2. Reservoir 
3. Automated 3way valve 
4. Spliter 
5. slide 
1 1 
2 
2 3 
3 
4 
4 
5 
Figures 4,5:  The main layout of the microfluidic experiment. Pc with uprocess program 
controlled pumps and valves.   
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2.9 Microfluidic experiment 
2.9.1 With 15 minutes of antigen wash through 
For the first experiment of the micro SP-PLA a channel of 15μm in depth and 30μm in width 
was used alongside with 1/32’’ tubings and a 1mL syringe attached to the Harvard apparatus 
pump device. The table shows duration, flow rates and volumes of each reagent: 
 antigen wash probes wash ligation wash amplification 
total volume (μL) 80 30 50 25 50 25 90 
Flow rate (μL/min) 5 5 5 5 5 5 1 
duration (min) 15 6 10 5 10 5 90 
  
Before the microfluidic procedure, the capture antibody was immobilized the previous day in a 
squared mask 22mm x 22mm and let for an overnight immobilization in 4ºC. Then, blocking 
buffer with salmon sperm DNA (0.1 mg/ml) was added and the incubation took place for 
30min in room temperature. The mask was then removed and the slide got into the automated 
compressed air slide holding device with all the other components.  
2.9.2 With 1 minute of antigen wash through 
 By keeping all the durations the same, only the one of antigen was changed just to push the 
method even further. So the duration that was chosen was only 1 minute, in a flow rate of 1 
μL/min and the concentration of antigen 100pM.  
2.10 Same duration in masks 
What makes a microfluidic experiment successful? Better signal, zero background, lower 
volumes and even lower duration. We wanted to assess the performance of the assay in a 
microfluidic environment and compare it to the results we already had. The background was 
tested alongside with 1 and 15 minutes of antigen incubation. All the other incubation times 
were the same as the ones in the microfluidic experiment. 
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3 Results 
 
3.1 The right concentration of capture antibody 
The right concentration of capture antibody was one of the most important parameters in the 
whole experiment because that would define how much of the antigen could be captured and 
detected. From the 4 concentrations used (0.5, 5, 50, 500 nM), 500 nM gave the best results 
according to the following images: 
 
The density of RCPs was so high that it was impossible to be counted. Though, background 
kept really low in all 4 concentrations. 
 
 
0.5 nM 5 nM
 
nM 
 0.5 nM 
 0.5 nM 
50 nM 500 nM 
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Background images (antigen minus) 
3.2 CodeLink vs. Sigolis 
The optimization of this method was performed 
only on the CodeLink slides because it was 
more efficient to use them and much easier.  
The signal was higher compared to Sigolis 
slides and the protocol time was significantly 
reduced by 90 mins. The diagram (figure 11) 
shows how the number of the counted RCPs 
changes with the different concentration of 
antibody in both slides. Sigolis slides had a 
very high signal in 10nM on antibody but less 
signal in 1nM, which is the concentration we 
used. The big drawback of the CodeLinks 
slides is the high background, which needed to 
be fixed by applying a very efficient blocking 
method.  
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Figure 11.  diagram of the antibody concentration 
and signal in Codelink and sigolis slides 
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3.3 Blocking with BSA 
Blocking with BSA was the first option in the blocking techniques. It is used widely in many 
immunoassays with good results. The diagram shows how number of RCPs changes with each 
different concentration of BSA. As it is demontrated, the more BSA added the less the signal. 
That suggests that perhaps BSA interacts with the antigen binding sites of the antibody causing  
block and making the antibody unable to detect and bind the antigen. Also the background 
seemed to deminish which means that  BSA can actually block the surface and reduce non 
specific binding, but the fact that true signal diminish made us explore alternative blocking 
strategies. 
 
Figure 12 diagram of signal and noise between different 
concentrations of BSA 
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3.4 Testing different blocking  
Different blocking solutions were used in order to find one that keeps the background in low 
levels while maintaning true signal. 3 different blockings were used: Blocking buffer, Super 
Block, Duolink’s blocking as well as no blocking.  
Blocking buffer 
Super Block 
Duolink's blocking 
No blocking 
Figure 13. Pictures of results of different blockings. The signal is shown in the left images whereas the background 
on the right ones. 
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Figure 14. diagram of the background using 
different blockings 
            
                              Antigen +                                                                     Antigen – 
On figure 13, the images of the results in 
different blockings are demonstrated.  
Notice that the signal is still too high to 
count RCPs, so in such concentrations of 
antigen the actual number of them cannot 
be estimated. Here we observed a 
tremendous difference between the signal 
that Super Block gives and the others. 
Super block was able to eliminate the 
background (figure 14) and make the all 
RCPs clear. 
 
 
 
3.5 Probe titrations 
The right concentration of probes will affect assay performance. Too high concentration could 
cause high background, and too low could cause loss of true signal.  
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Figure 18 sensitivity of method with 
optimized conditions 
 
 
Figures 15, 16, 17 show how the number of RCPs is affected by the different concentrations of 
probes alongside with different blocking buffers. With the bocking buffer, the 1:1 dilutant gave 
a maximum signal of approximately 12,000 RCPs, while the others failed to raise the signal in 
such high levels. The background in the 1:1 dilutant is also kept on low levels, making it 
possible for the signal to noise ratio to be in the highest levels.   
Assessing the effect of blocking, we observed that the difference is quite big. The average 
difference is approximately 3,000 RCPs making blocking buffer more efficient than no 
blocking in the 1:1 dilutant of probes. 
Last, we checked SuperBlock but the results showed that it is not as efficient as the Blocking 
Buffer. Consequently, the best dilution of probes to use was 1:1, corresponding to a 
concentration of 6,25μg/ml.    
 
3.6 Different concentrations of antigen 
with optimized conditions 
 
Having established different experimental 
conditions, we proceeded by assessing the 
sensitivity of the method. We were able to 
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Figures 15, 16, 17: Different blockings with 
different probe dilutions 
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accurately detect concentrations of the antigen as low as 1 pM (figure 18). 
 
 
 
 
 
 
3.7 Optimized protocol for SP-PLA on CodeLinks’ glass slides 
Optimized experimental conditions are as described: 
1. Dilute the capture antibody in carbonate buffer (pH=9,6) using the preferable 
concentration (500 nM) 
2. Place the antibody dilutant in the mask and let the immobilization proceed for 2 hours at 
Room Temperature (RT).  
3. Wash once with 1X PBS for 1-3 min  
4. Insert Blocking Buffer with salmon sperm DNA 0.1mg/ml and incubate for 30min at 
RT 
5. Wash once with 1X PBS  for 1-3min  
6. Add antigen. Then incubate for 2h in 37ºC 
7. Wash with Tween PBS  for 1-3min once 
8. Dilute DuoLinks’ probes at a 1:1 ratio and incubate for 60 min in 37ºC 
9. Wash once with Tween PBS  for 1-3min  
10. Procced with the ligation reaction, using Ligation stock from DuoLink in 1:5 dilution 
according to manufacturer’s instructions. 
11.  Wash once with Tween PBS  for 1-3min  
12. Add the amplification stock in dilution 1:5 according to manufacturer’s instructions. 
13. Wash with Tween PBS  for 1-3min once (last wash) 
14. Put the slides in ethanol series (70%, 85%, 99%) for 2 min respectively 
15. Use vectashield mounting medium and a cover glass to cover the slide 
16. Detect the signal in a fluorescence microscope in Cy 3.5 
17. Store slides in the dark at 4ºC for further analysis 
 
 
3.8 Micro SP- PLA 
With the optimized protocol for SP PLA it was possible to move and apply the method into 
microfluidics. In figure 19, point 1 represents the infusion point and point 15 the exit point 
of the microfluidic channel.  
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Infusion point Middle of the channel Exit point 
Figure 19.  RCPs through the channel with images of 3 points 
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Figure 20. Signal to noise ratio in logarithmic scale 
Another advantage of the microfluidic method is the fact that the background is almost 
eliminated (figure 20). The ratio between true signal and noise is very high and that gives 
promising results for the future. It will be really encouraging to use even lower concentrations 
of antigen and even lower volumes of all reagents.  
Next step was to reduce the antigen duration to only 1 minute, and concentration in 100pM. 
The diagram in that case was completely different (figure 21). All the RCPs in the whole 
channel were as low as the background, a clue that implies the inefficiency of the method to 
detect the antigen in such short duration. 
 
Figure 21 diagram of reduced time 
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We run the same experiment without the use of microfluidics in a 50μL mask.We were able to 
detect  signals over background in the samples that were incubated for both 15 and 1 minute, as 
shown in figure 22: 
 
Figure 22
2
 results with same durations in masks 
 
3.9 Efficiency of the method 
The fact that the signal is lower than the one in the mask, is concerning. Because of the nature 
of microfluidics, reactions times should be much lower, and efficiency of binding the antigen 
better. This suggests that perhaps because of the flow rate some of the RCA products that are 
bind with the capture antibody are washed away and so we lose most of the signal. It is sure 
though, that the background is almost zero, so we have gains in signal to noise ratio.     
 
4 Discusion 
 The design of the PLA technology demonstrates excellent sensitivity of detection which can 
reach even 1000-fold greater sensitivity than the commercially available ELISA. So, trying to 
optimize even further such techniques holds the key for creating one of the world’s most 
sensitive method. Diagnostics could benefit from an improvement in assay performance. 
Taking for example troponin I and T, molecules that are released in blood during myocardial 
infraction, are excellent biomarkers for it. The only problem is that they are found in the blood 
in extremely low concentrations (50-100 ng/dl) and a big amount of them is not so long after 
cardiac damage. Consequently, micro SP-PLA should be used as an excellent paradigm of such 
method. With its low duration and high sensitivity, this method could be commercially 
available to public and hospitals, making it possible for many human lives to be saved. 
                                                             
2
 The p- value was calculated by t- test 
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Unfortunately we are still to very beginning and we currently try to understand how 
microfluidics exactly work and behave under various conditions. The prototype device we 
made had some faults like inefficient way to hold tubes inside the microfluidic channels 
causing leaking of reagents. This, could cause non efficient flow through the channel and 
consequently stationary reagents. Furthermore it would be better for more flow rates and 
volumes to be tested. So far we tested 2 conditions, but the limited time didn’t gave us the 
chance to test more. Flow rates are really important because that could affect directly how 
efficient the reactions could be. For instance, high flow rates with high volumes of reagents 
could cause molecules to pass the channel so quickly that it would be impossible for any 
reaction to be completed. On the other hand, low flow rates with lower volumes could cause 
lack of the quantity of the reagents.  
We were able to overpass this problem by binding a new mask made of silicon on the glass 
slide by oxidation. The silicon mask was thicker than the one we used from sigolis, and also the 
entrance holes were tighter so that the tube could firmly fit in them. The only drawback was the 
fact that the immobilization of the capture antibody had to take place inside the microfluidic 
channel, which mend that the antibody should flow through it. So, practically that was a ‘flow 
immobilization’ with non-predictable results. Also, because of the inability to remove the 
silicon mask, the signal should be detected with a confocal microscope. The first results we got 
from this new approach were satisfying and promising (figure 23). Nevertheless more 
experiments and analysis need to be done to evaluate the efficiency and convenience of the new 
method.  
 
Figure 23 images demonstrating the results from the latest microfluidic experiment 
Another parameter that could be changed is the amplification process. We currently use RCA 
in order to amplify the signal into an RCP. This method takes about 1.5 hours to be 
accomplished, time that should be reduced. Future plans includes reducing the amplification 
duration by taking advantage of a new method called super rolling circle amplification (sRCA). 
During this assay, the time of reaction could reduce to only 15 minutes and also RCPs could be 
the same size and quality as the ones in the traditional RCA.   
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That consists the first step for this super-efficient method that can actually replace robotics or 
make them obsolate. Microfluidics gives us the advantage of tiny quantities of reagents and 
space. So, multiple samples could be analyzed simultaneously and automatically without any 
great effort from the scientist. 
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